Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3

J Pharmacol Exp Ther. 1999 Oct;291(1):1-6.

Abstract

The effects of fluoxetine (Prozac), a widely used antidepressant drug, on Kv1.3 stably expressed in Chinese hamster ovary cells were examined using the whole-cell and excised inside-out configurations of the patch-clamp technique. In whole-cell recordings, fluoxetine accelerated the decay rate of inactivation of Kv1.3 and thus decreased the current amplitude at the end of the pulse in a concentration-dependent manner with an IC(50) value of 5.9 microM. The inhibition displayed a weak voltage dependence, increasing at more positive potentials. Neither the activation nor the steady-state inactivation curve was affected by fluoxetine. In addition, fluoxetine reduced the tail current amplitude and slowed the deactivation of the tail current, resulting in a crossover phenomenon. When applied to the internal side of the membrane in inside-out recordings, the inhibition by fluoxetine was much faster and more potent with an IC(50) value of 1.7 microM compared with whole-cell recordings. Norfluoxetine, the major metabolite of fluoxetine, also inhibited Kv1.3 in a concentration-dependent manner (IC(50) = 1.4 microM) in whole-cell recordings. To check whether the fluoxetine-induced inhibition demonstrated in cloned Kv1.3 could also be observed in native T lymphocytes, the effects of fluoxetine were investigated on human T lymphocytes. Fluoxetine also inhibited outward K(+) current in human T lymphocytes. Our results indicate that fluoxetine produced a concentration- and voltage-dependent inhibition of Kv1.3 that can be interpreted as an open channel block and that a binding site for fluoxetine is more accessible from the intracellular side.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents, Second-Generation / metabolism
  • Antidepressive Agents, Second-Generation / pharmacology*
  • CHO Cells
  • Cricetinae
  • Electrophysiology
  • Fluoxetine / analogs & derivatives
  • Fluoxetine / metabolism
  • Fluoxetine / pharmacology*
  • Humans
  • Kv1.3 Potassium Channel
  • Potassium / metabolism
  • Potassium Channel Blockers*
  • Potassium Channels / physiology
  • Potassium Channels, Voltage-Gated*
  • Recombinant Proteins / antagonists & inhibitors
  • Recombinant Proteins / metabolism
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / physiology

Substances

  • Antidepressive Agents, Second-Generation
  • KCNA3 protein, human
  • Kv1.3 Potassium Channel
  • Potassium Channel Blockers
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Recombinant Proteins
  • Fluoxetine
  • norfluoxetine
  • Potassium